1 of 1
Story summary
- President Donald Trump announced a rule ending Medicaid funding for gender-affirming hormone treatments for transgender minors, effective October 2026.
- The rule lets hormone-therapy recipients keep Medicaid for six months.
- HHS Secretary Robert F. Kennedy Jr. said the policy protects children from irreversible procedures lacking evidence.
- CMS Administrator Mehmet Oz said rule follows evidence and that Kaiser Family Foundation data show 27 states have bans on gender-affirming care for minors.
